Links

Columnists



Site Search


Entire (RSS)
Comments (RSS)

Archive Calendar

October 2020
S M T W T F S
 123
45678910
11121314151617
18192021222324
25262728293031

Guides

How to Become a Bounty Hunter



Tag: opiods

DEA Wants to Increase Marijuana Research While Limiting Opioids Production

By Steve Neavling
Ticklethewire.com

The DEA is recommending an increase in the amount of marijuana grown for research while reducing the production of opioids.

The agency, which has long resisted research that could lead to the legalization of cannabis, wants to more than quintuple the amount of marijuana that can be grown for research, according to a DEA news release.

In an upcoming Federal Register filing, the amount of marijuana that could be produced for research would increase to about 5,400 pounds.

At the same time, the DEA wants to reduce the production of six types opioids by 10% over the next year.

It would be the third time the DEA has imposed limits on the amount of opioids made in the U.S.

Pharmaceutical Companies Hire DEA Agents Tasked with Cracking Down on Opioids

pillsBy Steve Neavling
ticklethewire.com

The pharmaceutical industry, which distributes highly addictive opioids that have lead to the heroin epidemic and nearly 180,000 overdoses in the past decade, has hired dozens of top-level DEA officials, the Boston Globe reveals. 

The DEA began an aggressive campaign to curb opioid use, and in 2005, agents began cracking down on companies that distribute the painkillers.

In the past decade, the pharmaceutical companies and their law firms have hired at least 42 DEA officials, most of whom were responsible for regulating the industry.

‘‘The number of employees recruited from that division points to a deliberate strategy by the pharmaceutical industry to hire people who are the biggest headaches for them,’’ said John Carnevale, a former director of planning for the White House’s Office of National Drug Control Policy who now runs a consulting firm. ‘‘These people understand how DEA operates, the culture around diversion and DEA’s goals, and they can advise their clients how to stay within the guidelines.’’

A pharmaceutical spokesman said the industry has been hiring experts in prescription drug.

‘‘Our industry is highly specialized, and the function of drug-diversion experts even more so,’’ said John M. Gray, chief executive of the Healthcare Distribution Alliance, which represents drug distributors. ‘‘As such, for these individuals who want to continue to grow in their areas of expertise, it is logical for them to pursue government and industry roles that are closely aligned with their professional experience.’’

The Boston Globe wrote, “The number of hires from one key division shows how an industry can potentially blunt a government agency’s aggressive attempts at enforcement.”